⌘K

Login Start Free

Home/Filings/4/0001209191-17-053003

4//SEC Filing

MENDELSOHN JOHN 4

Accession 0001209191-17-053003

CIK 0001274792other

View on SEC.gov Company Profile

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 4:42 PM ET

Size

5.1 KB

Accession

0001209191-17-053003

Insider Transaction Report

Form 4

Period: 2017-09-13

MERRIMACK PHARMACEUTICALS INCMACK

MENDELSOHN JOHN

Director

Transactions

Award
Stock Option (right to buy)
2017-09-13+7,500→ 7,500 total
Exercise: $13.99Exp: 2027-09-12→ Common Stock (7,500 underlying)

Footnotes (1)

[F1]This option is fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

MERRIMACK PHARMACEUTICALS INC

CIK 0001274792

Entity typeother

Related Parties

1

filerCIK 0001234382

Filing Metadata

Form type: 4
Filed: Sep 14, 8:00 PM ET
Accepted: Sep 15, 4:42 PM ET
Size: 5.1 KB

View on SEC.gov